Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline ProgressUnusual Whales·1 day ago, 03:17 PMCNTX-2727.00%
Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business UpdateUnusual Whales·1 day ago, 06:55 AMKYMR+88.00%
Kindred Companion Sciences Unveils First Dogs Genetically Edited to Remove the Major Dog AllergenUnusual Whales·2 days ago, 06:08 AM
Design Therapeutics Provides RESTORE-FA Clinical Development Update and Reports Second Quarter 2026 Financial ResultsUnusual Whales·Aug 3 at 07:03 AMDSGN+147.00%
ABPRO HOLDINGS INC C/WTS 12/11/2029 (TO PUR COM) | 10-Q: FY2026 Q1 Revenue: USD 0Earnings Watch·May 20 at 04:23 PMABPWW0.00%
ABPRO HOLDINGS INC C/WTS 12/11/2029 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 14, 2025 at 03:54 PMABPWW0.00%
ABPRO HOLDINGS INC C/WTS 12/11/2029 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.05Earnings Watch·Aug 13, 2025 at 03:19 PMABPWW0.00%
ABPRO HOLDINGS INC C/WTS 12/11/2029 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -0.08Earnings Watch·May 15, 2025 at 03:51 PMABPWW0.00%
